Skip to main content

Table 5 Multiple logistic regression analysis for initiating an antifibrotic treatment

From: Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland

Variable

OR

95% CI

p-value

Age 66–75 vs 50–65

0.75

0.33–1.68

0.48

Age over 75 vs 50–65

0.19

0.08–0.48

0.0004

Age 66–75 vs over 75

3.96

1.83–8.55

0.0005

FVC 75% or under vs FVC over 75%

1.73

0.86–3.48

0.13

DLCO/VA 55% or under vs DLCO/VA over 55%

1.83

0.92–3.64

0.086